Showing results (201-210 of 256) with videos related to
Sort By:
Pageof 26
AIDS Research and Human Retroviruses|August 24, 2000
Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinantsW Janssens, M O Salminen, T Laukkanen, et al.Clinical Immunology and Immunopathology|April 1, 1994
The interleukin-2 receptor subunit expression and function on peripheral blood lymphocytes from HIV-infected and control personsG Vanham, L Kestens, J Vingerhoets, et al.Vaccine|April 25, 2017
Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, UgandaE Seremba, J P Van Geertruyden, R Ssenyonga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon GroupB Löwenberg, S Suciu, E Archimbaud, et al.Journal of the American Academy of Dermatology|October 27, 1999
Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infectionR Colebunders, K Depraetere, T Verstraeten, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 10, 2012
Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosisA Conesa-Botella, O Goovaerts, M Massinga-Loembé, et al.Journal of Medical Virology|March 1, 1997
Virologic, immunologic, and clinical follow-up of a couple infected by the human immunodeficiency virus type one, group OJ N Nkengasong, K Fransen, B Willems, et al.AIDS Research and Human Retroviruses|October 6, 2000
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivoM P de Baar, W Janssens, A de Ronde, et al.AIDS (London, England)|June 16, 2001
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatmentW Schrooten, R Colebunders, M Youle, et al.AIDS Care|March 17, 2007
Assessment of the patient flow at the infectious diseases institute out-patient clinic, Kampala, UgandaR Colebunders, T Bukenya, N Pakker, et al.Pageof 26